Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Alliant Techsystems Inc. ( ATK - Analyst Report ) has received a contract worth $52.7 million from the Missile Defense Agency (“MDA”). The company’s Defense segment will take responsibility for this project.
Per the agreement, Alliant will provide its support to develop MDA’s Modular Divert and Attitude Control System (“MDACS”) technologies and will offer components for new MDACS system architecture for the longer mission timelines to counter the growing threats.
These technologies are appropriate for the Standard Missile-3 (“SM-3”) Block IIB missile interceptors. The company’s approach toward a ship-board compatible MDACS operation improves kinetic performance of the SM-3 Block II along with offering advancement to the missile’s performance.
Alliant’s MDACS propulsion system offers the impulse needed for the kinetic warhead to hit the specific targets. In addition, performing end-game maneuvers for final intercept, MDACS propulsion system, helps in maintaining stable flight.
Alliant has an experience of 35 years, with a strong engineering team to develop and manufacture missile defense Divert and Attitude Control System (“DACS”) and drive innovative solutions for future interceptors.
During the second quarter of fiscal 2013 earnings call, Alliant’s Defense segment reported a 9% drop in sales to $484 million from $528 million in the prior-year quarter. However, excluding the impacts of sales related to the Radford Army Ammunition Plant (“RFAAP”) and favorable contract resolution, the unit witnessed a 5% year-over-year rise in sales driven by higher sales of small caliber systems.
Alliant’s two biggest customers are the U.S. Department of Defense and the National Aeronautics and Space Administration. We believe that U.S. defense budget cutbacks could limit the company’s future growth prospects. In addition, higher degree of competition from a number of players in each of its business areas is also our major concern.
However, we expect this to be partially mitigated by up-cycle in the Aerospace segment, which will in turn contribute significantly to the company’s future profitability.
Considering the positive and negative factors, we prefer Alliant Techsystems to have a short-term Zacks #2 Rank (Buy rating). One of its peers Rockwell Collins Inc. ( COL - Analyst Report ) has short-term Zacks #3 Rank (Hold rating).
Arlington, Virginia-based Alliant Techsystems Inc. provides aerospace and defense products to the U.S. government agencies. The company also supplies ammunition and related accessories to law enforcement agencies and commercial customers. With a market capitalization of $1.98 billion, Alliant has 17,000 full time employees.
Read the full Analyst Report on COL
Read the full Analyst Report on ATK